NIAID R34: IND-directed Product Development Planning for HIV Treatments and Prevention (No Clinical Trials)
This NIAID R34 NOFO funds planning activities to develop IND-directed product development strategies for next-generation HIV treatments, comorbidities/coinfections therapies, and preventive interventions. Support includes building multidisciplinary teams and planning CMC, pharmacology/toxicology, regulatory strategies, and clinical protocol design (clinical trials are not allowed); applicants …
National Institute of Allergy and Infectious Diseases ( NIAID )-funded biomedical research has led to the discovery of novel promising biomedical strategies to treat and prevent HIV and other infectious diseases. Bringing newly discovered treatment and prevention interventions to an Investigatio…
Funding Source
Awards & funding
Eligibility
Foreign eligibility: Non-domestic (non-U.S.) entities (foreign organizations) are eligible to apply. Non-domestic (non-U.S.) components of U.S. organizations are eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
Required registrations (must…
Dates
Supporting links
Secure Grant Funding 10x Faster
Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.
Already have an account? Sign In
Trusted by 500+ Happy Customers